Simon Dingemans

Chairman at Genomics

Simon is an experienced former chief financial officer who combined a successful 25-year investment banking career with a position as Group CFO of GSK plc, the global healthcare group.

Simon stepped down from GSK in May 2019 after over eight years on the board which included helping to drive extensive restructuring and operational improvements, as well as several significant strategic transactions, including acquiring the Novartis vaccine business and creating a global scale consumer healthcare company, recently spun out as Haleon.

Currently, Simon is a Senior Advisor to The Carlyle Group, focused on the Healthcare sector as well as opportunities in the UK. Simon is also on the board of WPP plc, the creative transformation company, as a Non-executive Director, and recently completed four years as a Trustee and Chair of the Audit Committee of London based Donmar Theatre.

Links